Pay in 4 interest-free payments of $6.00 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Pregnant or breastfeeding women should not take GLP-1 medications
The market benefits from robust direct-to-consumer marketing efforts that drive patient demand and consultation rates
If cost, side effects, supply issues, limited results, or the thought of lifelong medication has you frustrated, weight loss surgery may offer a more durable path forward
Rybelsus and Trulicity are both FDA-approved GLP-1 receptor agonists that help regulate blood sugar levels in patients with type 2 diabetes, but they differ significantly in administration: Rybelsus is the first oral semaglutide (taken as a daily pill), while Trulicity (dulaglutide) requires a weekly injection
Injection site used
US$ 29.08
US$ 22.51
US$ 25.69
US$ 24.57
US$ 27.26
US$ 25.46
